Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and gsk 1363089

erlotinib hydrochloride has been researched along with gsk 1363089 in 2 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(gsk 1363089)		Trials
(gsk 1363089)		Recent Studies (post-2010) (gsk 1363089)
4,3537863,0331319124

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)gsk 1363089 (IC50)
Epidermal growth factor receptorHomo sapiens (human)1.5147
High affinity nerve growth factor receptorHomo sapiens (human)0.003
Acyl-CoA desaturase 1Rattus norvegicus (Norway rat)0.0004
Hepatocyte growth factor receptorHomo sapiens (human)0.056
Proto-oncogene tyrosine-protein kinase ROSHomo sapiens (human)0.01
Platelet-derived growth factor receptor betaHomo sapiens (human)0.0098
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.1814
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.2346
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.2541
Ephrin type-A receptor 2Homo sapiens (human)0.0019
Tyrosine-protein kinase receptor UFOHomo sapiens (human)0.0417
Delta-type opioid receptorMus musculus (house mouse)0.0049
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.003
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.1234
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.1806
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)2.99
Mu-type opioid receptorMus musculus (house mouse)0.0056
4-aminobutyrate aminotransferase, mitochondrialMus musculus (house mouse)0.0086
Angiopoietin-1 receptorHomo sapiens (human)0.0011
Macrophage-stimulating protein receptorHomo sapiens (human)0.1798
Homeodomain-interacting protein kinase 1Homo sapiens (human)0.1
Cyclin-dependent kinase-like 3Homo sapiens (human)7.9
Homeodomain-interacting protein kinase 4Homo sapiens (human)0.1
Homeodomain-interacting protein kinase 2Homo sapiens (human)0.1
Homeodomain-interacting protein kinase 3Homo sapiens (human)0.1
ALK tyrosine kinase receptorHomo sapiens (human)3.18

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, A; Gilmer, TM; Greger, J; Liu, L; Liu, Y; Martin, AM; Peterson, J; Shi, H1
Axel, U; Baska, F; Greff, Z; Gyulavári, P; Ibolya, K; Kéri, G; Orfi, L; Peták, I; Szántai, KC; Szokol, B; Vantus, T; Zoltán, O1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and gsk 1363089

ArticleYear
Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:3

    Topics: Anilides; Antibodies, Monoclonal; Apoptosis; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Hepatocyte Growth Factor; Humans; Immunoprecipitation; Lapatinib; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-met; Quinazolines; Quinolines; Receptor, ErbB-2; Receptors, Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2011
[Development and biochemical characterization of EGFR/c-Met dual inhibitors].
    Acta pharmaceutica Hungarica, 2013, Volume: 83, Issue:4

    Topics: Afatinib; Aminopyridines; Anilides; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Computer Simulation; Crizotinib; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Imidazoles; Lapatinib; Lung Neoplasms; Molecular Structure; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-met; Pyrazines; Pyrazoles; Pyridines; Pyridones; Quinazolines; Quinolines

2013